|
(P629) |
DGK-Abstract-Preis 2021:
Follow-up in healed mouse tumor model reveals high reversibility of cancer-induced cardiomyopathy but persistently impaired cardiac gene expression and high mortality after doxorubicin treatment |
| |
|
S. Pietzsch, M. Ricke-Hoch, K. Wohlan, S. Erschow, J. T. Thackeray, M. Scherr, D. Hilfiker-Kleiner (Hannover, Houston) |
|
(P630) |
Extra-cardiac immune-related adverse events in melanoma patients treated with immune checkpoint inhibitor therapy are associated with subclinical cardiac dysfunction |
| |
|
R. Mincu, J. Pohl, S. Mrotzek, L. Michel, L. Hinrichs, L. Lampe, T. Rassaf, M. Totzeck (Essen) |
|
(P631) |
Establishment of a cardio-oncology center- clinical practice and decision-making |
| |
|
S. Mrotzek, R. Mincu, A. Röll, T. Rassaf, M. Totzeck (Essen) |
|
(P633) |
Impact of cancer disease on periprocedural complications and long-term survival in patients undergoing transcatheter aortic valve replacement - a 13-years single center study |
| |
|
R. Mincu, A. Lind, A.-A. Mahabadi, R. A. Janosi, M. El Gabry, A. Ruhparwar, S. Mrotzek, L. Hinrichs, M. Akdeniz, M. Totzeck, T. Rassaf (Essen) |
|
(P634) |
Cysteine-rich angiogenic inducer 61 (Cyr61, CCN1) is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy |
| |
|
R. Klingenberg, S. Groß, K. Lehnert, D. Wegner, C. W. Hamm, S. B. Felix, T. Keller, M. Dörr (Bad Nauheim, Greifswald, Gießen) |
|
(P635) |
Serum drug concentration and cardiotoxicity in patients with heart failure and depression treated with escitalopram: Insights from the MOOD-HF randomized clinical trial |
| |
|
L. Barthel, S. Unterecker, S. Lezius, S. Störk, K. Wegscheider, G. Ertl, J. Deckert, C. E. Angermann, für die Studiengruppe: MOOD-HF (Würzburg, Hamburg) |
|
(P636) |
DGK-Abstract-Preis 2021:
Depression impacts perception of disease severity in patients with aortic stenosis irrespective of cardiac damage and improves after TAVI |
| |
|
G. Dannberg, L. Bäz, C. Lasch, M. Puscholt, T. Kräplin, M. Diab, S. Möbius-Winkler, C. Schulze, M. Franz (Jena) |
|
(P637) |
A comparative analysis of cardiac outcomes in COVID-19 pneumonias and pneumonias of other origin requiring mechanical ventilation |
| |
|
P. Jirak, R. Larbig, Z. Shomanova, E. Fröb, D. Dankl, C. Torgersen, N. Frank, M. Mahringer, D. Butkiene, H. Haake, H. Salzer, T. Tschoellitsch, M. Lichtenauer, A. Egle, B. Lamprecht, H. Reinecke, U. C. Hoppe, L. J. Motloch, R. Pistulli (Salzburg, Linz, AT; Mönchengladbach, Münster) |
|
(P638) |
Systolic ejection time – a simple tool with differential prognostic yield in patients with acute heart failure and reduced versus preserved left ventricular ejection fraction |
| |
|
C. Morbach, I. Simon, E. Danner, U. Stefenelli, F. Sahiti, N. Scholz, V. Cejka, J. Albert, G. Güder, G. Ertl, C. E. Angermann, S. Frantz, C. Maack, S. Störk (Würzburg) |
|
(P639) |
Catheter Ablation for Atrial Fibrillation in HFpEF Patients – a Propensity-Score matched Analysis |
| |
|
M. Rattka, A. Kühberger, A. Pott, T. Stephan, K. Weinmann, M. Baumhardt, D. Aktolga, Y. Teumer, C. Bothner, D. Scharnbeck, W. Rottbauer, T. Dahme (Ulm) |
|
(P640) |
Clonal hematopoiesis of indeterminate potential (CHIP)-related mutations in patients with heart failure both with dilated and ischemic cardiomyopathy: incidence and clinical significance |
| |
|
M. F. WU, T. Bekfani, A. Hinze, A. Waldau, T. Stöcker, S. Möbius-Winkler, A. Hochhaus, C. Schulze, T. Ernst (Jena, Magdeburg) |
